Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Jupiter Neurosciences (JUNS) Income from Continuing Operations (2024 - 2025)

Jupiter Neurosciences (JUNS) has disclosed Income from Continuing Operations for 2 consecutive years, with 2871248.0 as the latest value for Q4 2025.

  • Quarterly Income from Continuing Operations fell 93.55% to 2871248.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 8941114.0 through Dec 2025, down 168.17% year-over-year, with the annual reading at 8974741.0 for FY2025, 169.18% down from the prior year.
  • Income from Continuing Operations for Q4 2025 was 2871248.0 at Jupiter Neurosciences, down from 2288034.0 in the prior quarter.
  • The five-year high for Income from Continuing Operations was 600906.0 in Q3 2024, with the low at 2871248.0 in Q4 2025.